Overview
Hiroaki Taniguchi practices in Sasebo, Japan. Mr. Taniguchi is rated as an Advanced expert by MediFind in the treatment of Pulmonary Alveolar Proteinosis. His top areas of expertise are Adult T-Cell Leukemia, Pulmonary Alveolar Proteinosis, Leukemia, and Myelodysplastic Syndrome (MDS).
His clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pulmonary Alveolar Proteinosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult T-Cell LeukemiaMr. Taniguchi isAdvanced. Learn about Adult T-Cell Leukemia.
- Pulmonary Alveolar ProteinosisMr. Taniguchi isAdvanced. Learn about Pulmonary Alveolar Proteinosis.
- Experienced
- LeukemiaMr. Taniguchi isExperienced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Taniguchi isExperienced. Learn about Myelodysplastic Syndrome (MDS).